Breaking News Instant updates and real-time market news.

2021-12-06 04:32:39 JBAXY Julius Baer $12.55 / -0.21 (-1.65%) 04:32 12/06/21 12/06 04:32 12/06/21 04:32	Julius Baer upgraded to Buy from Neutral at UBS UBS analyst Daniele Brupbacher upgraded Julius Baer to Buy from Neutral with a price target of CHF 71, up from CHF 63.

2021-12-06 04:32:39

JBAXY

Julius Baer

$12.55 / -0.21 (-1.65%)

04:32

12/06/21

12/06

04:32

12/06/21

04:32

Julius Baer upgraded to Buy from Neutral at UBS

UBS analyst Daniele Brupbacher upgraded Julius Baer to Buy from Neutral with a price target of CHF 71, up from CHF 63.

OTHER BREAKING NEWS FROM THE FLY

Options	Apple call buyer realizes 8% same-day gains » 08:00 06/27/22 06/27 08:00 06/27/22 08:00 AAPL Apple $141.87 / +3.61 (+2.61%) Notable profits for the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AAPL Apple $141.87 / +3.61 (+2.61%) 06/19/22 Apple store workers in Maryland vote to form first U.S. union 06/14/22 Apple says new 13-inch MacBook Pro available to order starting June 17 06/14/22 Apple announces partnership to present Major League Soccer matches 06/12/22 Fly Intel: Top five weekend stock stories AAPL Apple $141.87 / +3.61 (+2.61%) 07:05 Today Bernstein Apple TV+ may have 20M-40M paying subscribers, says Bernstein 06/23/22 Bernstein Bernstein worries Apple EPS estimates for 2023 may be too high 06/22/22 BofA Apple App Store growth up 6% in fiscal Q3-to-date, says BofA 06/21/22 UBS Apple iPhone shipments in China post 'strong rebound', says UBS AAPL Apple $141.87 / +3.61 (+2.61%) 04/28/22 Apple says y/y Q3 revenue growth to be impacted by COVID 04/28/22 Apple reports Q2 EPS $1.52, consensus $1.43 04/28/22 Notable companies reporting after market close 02/27/22 Berkshire operating earnings surge, Buffett repurchases record $27B in stock AAPL Apple $141.87 / +3.61 (+2.61%) 05:47 Today Apple embarking on 'ambitious' period of products, Bloomberg's Gurman reports 06/24/22 Disney, Apple, Amazon bid on NFL's Sunday Ticket, CNBC reports 06/24/22 Analyst says Apple likely to unveil AR/MR headset in January, 9to5Mac says 06/17/22 TSMC to start 2nm processor production by 2025, Nikkei Asia reports AAPL Apple $141.87 / +3.61 (+2.61%) 06/15/22 #SocialStocks: Elon Musk set to address Twitter employees 06/14/22 What You Missed On Wall Street On Tuesday 06/13/22 What You Missed On Wall Street On Monday 06/13/22 What You Missed On Wall Street This Morning AAPL Apple $141.87 / +3.61 (+2.61%) 06/24/22 Notable open interest changes for June 24th 06/23/22 Notable open interest changes for June 23rd 06/22/22 Notable open interest changes for June 22nd 06/21/22 Notable open interest changes for June 21st
Hot Stocks	Stealth BioTherapeutics Corporation (ADS) trading resumes 08:00 06/27/22 06/27 08:00 06/27/22 08:00 MITO Stealth Biotherapeutics / + ShowHide Related Items >><< Company News Street Research Earnings MITO Stealth Biotherapeutics / + 07:28 Today Stealth BioTherapeutics Corporation (ADS) trading halted, news pending 06/14/22 Stealth Biotherapeutics to meet with FDA DCN to discuss NDA for Elamipretide 06/08/22 Stealth Biotherapeutics' SBT-272 shows motor neuron improvement in study 05/31/22 Stealth granted orphan drug designation for elamipretide by EMA MITO Stealth Biotherapeutics / + 05/23/22 H.C. Wainwright Stealth Biotherapeutics price target lowered to $1.50 from $4 at H.C. Wainwright 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim 07/01/21 Maxim Stealth Biotherapeutics initiated with a Buy at Maxim MITO Stealth Biotherapeutics / + 07:34 Today Stealth Biotherapeutics announces receipt of preliminary non-binding proposal
Recommendations	UDR price target lowered to $48 from $60 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 UDR UDR $46.14 / +0.435 (+0.95%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate UDR UDR $46.14 / +0.435 (+0.95%) 05/23/22 UDR names Joe Fisher as President and CFO UDR UDR $46.14 / +0.435 (+0.95%) 06/24/22 Truist UDR price target lowered to $50 from $53 at Truist 06/22/22 Credit Suisse UDR initiated with an Outperform at Credit Suisse 05/24/22 Truist UDR price target lowered to $53 from $61 at Truist 05/19/22 Scotiabank UDR price target lowered to $58 from $60 at Scotiabank UDR UDR $46.14 / +0.435 (+0.95%) 04/26/22 UDR raises FY22 AFFO view to $2.05-$2.11 from $2.02-$2.10, consensus $2.28 04/26/22 UDR sees Q2 AFFO 50c-52c 04/26/22 UDR reports Q1 AFFO 51c, consensus 55c 02/08/22 UDR sees FY AFFO $2.02-$2.10, consensus $2.26 30 Mar
Recommendations	MAA price target lowered to $178 from $221 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 MAA MAA $172.59 / +2.33 (+1.37%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate MAA MAA $172.59 / +2.33 (+1.37%) 05/17/22 MAA increases dividend 15% to $1.25 MAA MAA $172.59 / +2.33 (+1.37%) 06/24/22 Truist MAA price target lowered to $188 from $205 at Truist 06/22/22 Credit Suisse MAA initiated with an Outperform at Credit Suisse 05/24/22 Truist MAA price target lowered to $205 from $220 at Truist 05/19/22 Scotiabank MAA price target lowered to $226 from $231 at Scotiabank MAA MAA $172.59 / +2.33 (+1.37%) 04/27/22 MAA raises FY22 core FFO view to $7.92-$8.24 from $7.74-$8.10, consensus $8.02 04/27/22 MAA still sees FY22 core FFO $6.95-$7.31, consensus $8.02 04/27/22 MAA reports Q2 core AFFO $1.85 vs. $1.54 a year ago 04/27/22 MAA reports Q1 core FFO $1.97, consensus $1.92 03 Aug
Hot Stocks	Imperial Oil receives acceptance from TSX to purchase up to 5% of shares » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 IMO Imperial Oil $46.82 / +2 (+4.46%) , XOM Exxon Mobil $86.90 / +1.69 (+1.98%) Imperial Oil (IMO)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 06/23/22 Imperial Oil and E3 Lithium in lithium pilot project pact in Alberta 06/13/22 Imperial Oil announces preliminary results of its substantial issuer bid 02/01/22 Imperial Oil increases quarterly dividend 26% to 34c per share XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/22/22 President Biden calls on Congress to suspend federal gas tax 06/21/22 Exxon Mobil to hold 25% interest in new LNG joint venture in Qatar 06/15/22 Exxon Mobil 'in regular contact' with Biden administration on U.S. investments 05/25/22 Exxon Mobil says focused on five priorities to grow shareholder value IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 06/16/22 National Bank Imperial Oil price target raised to C$93 from C$80 at National Bank 06/16/22 RBC Capital Imperial Oil price target raised to C$78 from C$66 at RBC Capital 06/08/22 Scotiabank Imperial Oil price target raised to C$80 from C$72 at Scotiabank 05/12/22 RBC Capital Imperial Oil price target raised to C$66 from C$65 at RBC Capital XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/21/22 Credit Suisse Exxon Mobil upgraded to Outperform from Neutral at Credit Suisse 06/07/22 Evercore ISI Evercore upgrades Exxon Mobil, sees 'achievable' path to doubling earnings 06/07/22 Credit Suisse Exxon Mobil price target raised to $115 from $102 at Credit Suisse 06/07/22 Evercore ISI Exxon Mobil upgraded to Outperform from In Line at Evercore ISI IMO XOM IMO Imperial Oil $46.82 / +2 (+4.46%) 02/01/22 Imperial Oil reports Q4 EPS C$1.18 vs (C$1.56) last year XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 04/29/22 Exxon Mobil reports Q1 adjusted EPS $2.07, consensus $2.12 04/28/22 Notable companies reporting before tomorrow's open 04/28/22 Notable companies reporting before tomorrow's open 02/01/22 Exxon Mobil reports Q4 ex-items EPS $2.05, consensus $1.93 XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/15/22 Biden calls on oil refiners to boost supply of gas, diesel, CNBC reports 06/14/22 Finance chair to propose surtax on excessive oil company profits, Bloomberg says 06/10/22 Exxon, Chevron CEOs met with White House's Brian Deese, CNBC reports 06/10/22 Biden accuses U.S. oil industry of capitalizing on supply shortage, Reuters says XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 What You Missed On Wall Street On Wednesday XOM XOM Exxon Mobil $86.90 / +1.69 (+1.98%) 06/10/22 Early notable gainers among liquid option names on June 10th 06/08/22 Notable open interest changes for June 8th 06/07/22 Early notable gainers among liquid option names on June 7th 06/03/22 Early notable gainers among liquid option names on June 3rd

Recommendations	Essex Property Trust price target lowered to $273 from $342 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 ESS Essex Property Trust $261.65 / +2.06 (+0.79%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 02/24/22 Essex Property Trust raises annual dividend 5.3% ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06:04 Today Piper Sandler Essex Property Trust price target lowered to $340 from $400 at Piper Sandler 06/24/22 Truist Essex Property Trust price target lowered to $299 from $323 at Truist 06/22/22 Credit Suisse Essex Property Trust initiated with an Underperform at Credit Suisse 06/09/22 Stifel Essex Property Trust price target lowered to $352 from $390 at Stifel ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06/03/22 Essex Property Trust raises FY22 core FFO view to $14.00-$14.32 06/03/22 Essex Property Trust raises Q2 core FFO view to $3.55-$3.61 from $3.43-$3.55 04/26/22 Essex Property Trust sees FY22 core FFO $13.77-$14.13 from $13.46-$13.94 04/26/22 Essex Property Trust reports Q1 core FFO $3.37, consensus $3.34 ESS Essex Property Trust $261.65 / +2.06 (+0.79%) 06/06/22 What You Missed On Wall Street On Monday 06/06/22 What You Missed On Wall Street This Morning
Recommendations	Equity Residential price target lowered to $79 from $84 at Mizuho » 07:59 06/27/22 06/27 07:59 06/27/22 07:59 EQR Equity Residential $71.82 / -0.225 (-0.31%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings EQR Equity Residential $71.82 / -0.225 (-0.31%) 06/24/22 Truist Equity Residential price target lowered to $79 from $85 at Truist 06/22/22 Credit Suisse Equity Residential initiated with an Outperform at Credit Suisse 06/22/22 RBC Capital RBC Capital upgrades Equity Residential to Outperform on coastal exposure 06/22/22 RBC Capital Equity Residential upgraded to Outperform from Sector Perform at RBC Capital EQR Equity Residential $71.82 / -0.225 (-0.31%) 04/26/22 Equity Residential sees Q2 normalized FFO 82c-86c 04/26/22 Equity Residential reports Q1 normalized FFO 77c, consensus 80c 02/01/22 Equity Residential sees FY22 normalized FFO $3.40-$3.50, consensus $3.32 02/01/22 Equity Residential sees Q1 normalized FFO 76c-80c
Recommendations	Camden Property price target lowered to $142 from $170 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 CPT Camden Property $135.13 / +0.53 (+0.39%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate CPT Camden Property $135.13 / +0.53 (+0.39%) 04/04/22 Matador to replace Camden Property in S&P 400 at open on 4/4 04/04/22 Camden Property to replace People's United in S&P 500 at open on 4/4 03/29/22 Matador to replace Camden Property in S&P 400 at open on 4/4 03/29/22 Camden Property to replace People's United in S&P 500 at open on 4/4 CPT Camden Property $135.13 / +0.53 (+0.39%) 06/24/22 Truist Camden Property price target lowered to $149 from $160 at Truist 06/24/22 Baird Camden Property price target lowered to $153 from $175 at Baird 05/25/22 Truist Camden Property price target lowered to $160 from $186 at Truist 05/19/22 Scotiabank Camden Property price target lowered to $171 from $179 at Scotiabank CPT Camden Property $135.13 / +0.53 (+0.39%) 04/28/22 Camden Property sees Q2 FFO $1.60-$1.64 04/28/22 Camden Property raises FY22 FFO view to $6.39 - $6.63 from $6.09-$6.39 04/28/22 Camden Property reports Q1 AFFO $1.37, consensus $1.49 02/03/22 Camden Property sees Q1 FFO $1.45-$1.49, consensus $1.49 08 Apr
Recommendations	AvalonBay price target lowered to $212 from $260 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 AVB AvalonBay $195.14 / -1.415 (-0.72%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AVB AvalonBay $195.14 / -1.415 (-0.72%) 06/03/22 AvalonBay says two-month Same Store Residential rental revenue up 13% 04/05/22 PS Business Parks names Stephen Wilson as CEO, effective immediately 03/04/22 AvalonBay reports QTD same store residential rental revenue up 7.3% y/y 01/18/22 PS Business Parks names Stephen Wilson interim CEO AVB AvalonBay $195.14 / -1.415 (-0.72%) 06/24/22 Truist AvalonBay price target lowered to $224 from $263 at Truist 06/22/22 Credit Suisse AvalonBay initiated with a Neutral at Credit Suisse 05/19/22 Scotiabank AvalonBay price target lowered to $238 from $262 at Scotiabank 05/10/22 Barclays AvalonBay price target lowered to $229 from $263 at Barclays AVB AvalonBay $195.14 / -1.415 (-0.72%) 04/27/22 AvalonBay sees FY22 core FFO $9.38-$9.78, consensus $9.55 04/27/22 AvalonBay sees Q2 core FFO $2.25-$2.37 04/27/22 AvalonBay reports Q1 core FFO $2.26, consensus $2.26 02/02/22 AvalonBay sees FY22 core FFO $9.30-$9.80, consensus $9.39 07 Apr AVB AvalonBay $195.14 / -1.415 (-0.72%) 04/06/22 Fly Intel: After-Hours Movers
Recommendations	Apartment Income REIT price target lowered to $45 from $59 at Mizuho » 07:58 06/27/22 06/27 07:58 06/27/22 07:58 AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) Mizuho analyst Haendel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 06/23/22 Westwater Resources CFO Jeffrey Vigil to retire, Steven Cates to succeed 03/28/22 Apartment Income REIT CFO sells $766K in common stock AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 06/24/22 Truist Apartment Income REIT price target lowered to $45 from $49 at Truist 05/25/22 Truist Apartment Income REIT price target lowered to $49 from $58 at Truist 05/19/22 Scotiabank Apartment Income REIT price target lowered to $53 from $56 at Scotiabank 05/09/22 BTIG Apartment Income REIT initiated with a Neutral at BTIG AIRC Apartment Income REIT $41.36 / +0.02 (+0.05%) 05/02/22 Apartment Income REIT now sees FY FFO $2.37-$2.45, consensus $2.41 05/02/22 Apartment Income REIT reports Q1 FFO 57c, consensus 57c

Hot Stocks	Trump Media issues statement on Digital World Acquisition Corp. SEC filing » 07:55 06/27/22 06/27 07:55 06/27/22 07:55 DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) Trump Media &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 07:32 Today Digital World Acquisition says Garelick to resign from board 07:31 Today Trump-linked SPAC Digital World reports receipt of grand jury subpoena 06/15/22 Digital World Acquisition working toward consummating combination w/ Trump Media 06/13/22 Digital World Acquisition says SEC recently issued further subpoena DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/06/22 Truth Social CEO says Trump 'encouraged' Musk to buy Twitter, NYP reports 04/20/22 Digital World Acquisition named as short idea by Kerrisdale Capital 04/15/22 Fox News says didn't authorize account on Truth Social, Axios reports 04/12/22 Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 05/18/22 #SocialStocks: Musk and Twitter working to close $44B deal, despite noise 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 05/01/22 Week in SPAC News: Trump-linked SPAC in spotlight as Musk buys Twitter DWAC Digital World Acquisition $27.81 / -0.06 (-0.22%) 06/24/22 Largest borrow rate increases among liquid names 06/17/22 Digital World Acquisition Corp put volume heavy and directionally bearish 06/15/22 Unusually active option classes on open June 15th 06/13/22 Digital World Acquisition Corp put volume heavy and directionally bearish
Recommendations	Amedisys' Contessa finalizing '9-figure revenue contract,' says Jefferies » 07:51 06/27/22 06/27 07:51 06/27/22 07:51 AMED Amedisys $115.40 / +0.11 (+0.10%) After having hosted… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AMED Amedisys $115.40 / +0.11 (+0.10%) 06/24/22 Memorial Hermann, Contessa partner for new at-home care options 06/09/22 Amedisys releases inaugural ESG Report 06/09/22 Baylor Scott & White Health an Amedisy announce home care partnership 04/26/22 Amedisys promotes Muscato as Chief Strategy Officer AMED Amedisys $115.40 / +0.11 (+0.10%) 06/22/22 Benchmark Benchmark doesn't expect proposed Medicare home health cut to make final rule 06/21/22 BofA Amedisys cut to Underperform at BofA after CMS proposal on home health rates 06/21/22 BofA Amedisys downgraded to Underperform from Neutral at BofA 06/21/22 Deutsche Bank Amedisys price target lowered to $175 from $210 at Deutsche Bank AMED Amedisys $115.40 / +0.11 (+0.10%) 04/27/22 Amedisys sees FY22 adjusted EPS $5.23-$5.45, consensus $5.33 04/27/22 Amedisys reports Q1 adjusted EPS $1.23, consensus $1.12 02/23/22 Amedisys sees FY22 EPS $5.23-$5.45, consensus $5.84 02/23/22 Amedisys reports Q4 EPS $1.18, consensus $1.18
Hot Stocks	Cronos Group announces partnership with Geocann » 07:49 06/27/22 06/27 07:49 06/27/22 07:49 CRON Cronos Group $3.11 / +0.155 (+5.25%) Cronos Group announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CRON Cronos Group $3.11 / +0.155 (+5.25%) 06/21/22 Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone 06/21/22 Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO 03/01/22 Cronos Group announces planned exit of Peace Naturals Campus in Ontario CRON Cronos Group $3.11 / +0.155 (+5.25%) 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC 05/11/22 Canaccord Cronos Group upgraded to Hold from Sell at Canaccord CRON Cronos Group $3.11 / +0.155 (+5.25%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CRON Cronos Group $3.11 / +0.155 (+5.25%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says CRON Cronos Group $3.11 / +0.155 (+5.25%) 06/23/22 Here's What You Missed in Cannabis This Week 06/16/22 Here's What You Missed in Cannabis This Week 06/09/22 Rising High: Exclusive talk with cannabis testing firm Green Scientific 06/02/22 Here's What You Missed in Cannabis This Week CRON Cronos Group $3.11 / +0.155 (+5.25%) 03/25/22 Unusually active option classes on open March 25th
Hot Stocks	Freyr announces Minister of Trade, Industry launched Norwegian battery strategy » 07:45 06/27/22 06/27 07:45 06/27/22 07:45 FREY Freyr Battery $6.93 / -0.005 (-0.07%) FREYR Battery welcomes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/15/22 Freyr Battery concludes raw material pacts to supply battery materials 05/25/22 Freyr Battery signs heads of terms for renewable power with Statkraft 05/18/22 Freyr Battery signs agreement with Vaasa for lease of 130 hectares of land 05/16/22 David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1 FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/20/22 Goldman Sachs Freyr Battery initiated with a Neutral at Goldman Sachs 03/17/22 US Capital Advisors Freyr Battery initiated with a Buy at US Capital Advisors 01/26/22 Clarksons Platou Freyr Battery initiated with a Buy at Clarksons Platou 01/04/22 Morgan Stanley Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos FREY Freyr Battery $6.93 / -0.005 (-0.07%) 05/11/22 Freyr Battery reports Q1 EPS (30c), consensus (14c) FREY Freyr Battery $6.93 / -0.005 (-0.07%) 06/15/22 Fly Intel: Pre-market Movers 01/19/22 Wall Street in Fives - Must Read Lists for Wednesday 01/19/22 Wall Street in Fives - Must Read Lists at Midday FREY Freyr Battery $6.93 / -0.005 (-0.07%) 04/28/22 FREYR Battery call volume above normal and directionally bullish
Conference/Events	Relay Therapeutics to hold virtual event » 07:45 06/27/22 06/27 07:45 06/27/22 07:45 RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) Virtual Investor and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 01/27/22 Relay Therapeutics treatment of cholangiocarcinoma granted orphan designation 01/04/22 Relay first patient dosed in trial of RLY-2608, initiates RLY-4008 expansion RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 06/06/22 Jefferies Relay Therapeutics initiated with an Underperform at Jefferies 05/10/22 H.C. Wainwright Relay Therapeutics price target lowered to $47 from $54 at H.C. Wainwright 05/09/22 JMP Securities Relay Therapeutics price target lowered to $35 from $50 at JMP Securities 02/01/22 Berenberg Relay Therapeutics initiated with a Buy at Berenberg RLAY Relay Therapeutics $20.87 / +1.87 (+9.84%) 05/05/22 Relay Therapeutics reports Q1 EPS (57c), consensus (62c) 02/24/22 Relay Therapeutics reports Q4 EPS ($3.82), consensus (58c) 13 Oct 08:00 Today Relay Therapeutics

Recommendations	Altria Group price target lowered to $45 from $56 at Cowen » 07:43 06/27/22 06/27 07:43 06/27/22 07:43 MO Altria Group $43.41 / +0.905 (+2.13%) Cowen analyst Vivien Azer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Juul to seek stay of FDA decision, exploring 'all options' under law 06/23/22 FDA denies authorization to market JUUL products 06/23/22 FDA denies authorization to market JUUL products 04/28/22 FDA proposes rules prohibiting menthol cigarettes and flavored cigars MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Morgan Stanley Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley 06/22/22 Goldman Sachs Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs 06/22/22 Stifel Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel 06/22/22 Jefferies FDA lowered nicotine rule likely to take many years to implement, says Jefferies MO Altria Group $43.41 / +0.905 (+2.13%) 05/19/22 Altria Group backs FY22 adjusted EPS view $4.79-$4.93, consensus $4.86 04/28/22 Altria Group backs FY22 adjusted EPS $4.79-$4.93, consensus $4.84 04/28/22 Altria Group reports Q1 adjusted EPS $1.12, consensus $1.18 04/27/22 Notable companies reporting before tomorrow's open MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 Appeals court halts FDA's ban on Juul e-cigarettes, AP reports 06/22/22 FDA to order Juul to take e-cigarettes off U.S. market, WSJ reports 06/21/22 Biden administration plans move to reduce nicotine in cigarettes, WaPo reports MO Altria Group $43.41 / +0.905 (+2.13%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/23/22 What You Missed On Wall Street On Thursday 07/28/22 Altria Group - MO MO Altria Group $43.41 / +0.905 (+2.13%) 06/23/22 Unusually active option classes on open June 23rd 06/22/22 Altria Group put volume heavy and directionally bearish 06/22/22 Unusually active option classes on open June 22nd 05/10/22 Unusually active option classes on open May 10th
Recommendations	Rockwell Automation price target lowered to $260 from $277 at Morgan Stanley » 07:42 06/27/22 06/27 07:42 06/27/22 07:42 ROK Rockwell Automation $201.07 / +3.735 (+1.89%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/23/22 HP Inc. names Ernest Nicolas as chief supply chain officer 05/03/22 Rockwell Automation CEO: It was a tough quarter, below our expectations 05/03/22 Rockwell Automation falls -13.9% 05/03/22 Rockwell Automation board authorizes additional $1B for share repurchases ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/24/22 Barclays Rockwell Automation price target lowered to $200 from $220 at Barclays 05/10/22 HSBC Rockwell Automation price target lowered to $240 from $293 at HSBC 05/05/22 JPMorgan Rockwell Automation price target lowered to $200 from $220 at JPMorgan 05/04/22 Oppenheimer Rockwell Automation price target lowered to $290 from $360 at Oppenheimer ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/03/22 Rockwell cuts FY22 revenue growth view to 11% - 15% from 16% - 19% 05/03/22 Rockwell Automation cuts FY22 EPS view to $9.20 - $9.80 from $10.50 - $11.10 05/03/22 Rockwell Automation reports Q2 EPS $1.66, consensus $2.26 05/02/22 Notable companies reporting before tomorrow's open ROK Rockwell Automation $201.07 / +3.735 (+1.89%) 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 05/03/22 Fly Intel: Pre-market Movers 01/27/22 Wall Street in Fives - Must Read Lists for Thursday
Recommendations	Roche price target lowered to $48 from $58 at Cowen » 07:41 06/27/22 06/27 07:41 06/27/22 07:41 RHHBY Roche $41.64 / +1.63 (+4.07%) Cowen analyst Steve Scala… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $41.64 / +1.63 (+4.07%) 06/16/22 FTC says to ramp up enforcement against illegal drug rebate schemes 06/16/22 Roche launches human papillomavirus self-sampling solution 06/16/22 Roche says crenezumab did not slow decline in autosomal dominant Alzheimer's 06/15/22 Roche announces FDA EUA for cobas SARS-CoV-2 Duo RHHBY Roche $41.64 / +1.63 (+4.07%) 06/02/22 Piper Sandler Piper ups Repare Therapeutics target after 'great deal' with Roche 05/19/22 Credit Suisse Roche price target lowered to CHF 350 from CHF 370 at Credit Suisse 05/13/22 Jefferies Roche downgraded to Hold from Buy at Jefferies 05/12/22 Morgan Stanley Roche price target lowered to CHF 370 from CHF 395 at Morgan Stanley RHHBY Roche $41.64 / +1.63 (+4.07%) 04/25/22 Roche reports Q1 group sales CHF 16.445B vs. CHF 14.93B last year 02/03/22 Roche sees FY22 core earnings growing in low- to mid-single digit range 02/03/22 Roche reports 2021 core EPS CHF 19.81 vs CHF 19.16 RHHBY Roche $41.64 / +1.63 (+4.07%) 02/24/22 Drugmakers criticize Medicare proposal on Biogen's Alzheimer's drug, WSJ says 02/09/22 Credit Suisse shareholders to block moves to extend Schwan's tenure, FT reports RHHBY Roche $41.64 / +1.63 (+4.07%) 06/02/22 What You Missed On Wall Street This Morning 01/13/22 Meet Prothena: Fly exclusive interview with CEO Gene Kinney 07/21/22 Roche - RHHBY
Hot Stocks	Accenture to acquire XtremeEDA, terms not disclosed » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 ACN Accenture $299.36 / +13.3 (+4.65%) Accenture "has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 Johnson Controls, Accenture partner on OpenBlue Innovation Centers 06/23/22 Accenture raises FY22 negative FX impact view to 4.5% from 3% 06/23/22 Accenture sees FY22 operating cash flow $8.7B-$9.2B 06/06/22 Accenture acquires technology consultancy and managed services provider Advocate ACN Accenture $299.36 / +13.3 (+4.65%) 06/25/22 Barclays Accenture price target lowered to $370 from $455 at Barclays 06/24/22 RBC Capital Accenture price target lowered to $357 from $435 at RBC Capital 06/24/22 Cowen Accenture price target lowered to $325 from $330 at Cowen 06/24/22 Baird Accenture price target lowered to $310 from $340 at Baird ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 Accenture sees Q4 revenue $15B-$15.5B, consensus $14.83B 06/23/22 Accenture narrows FY22 EPS view to $10.61-$10.70 from $10.61-$10.81 06/23/22 Accenture reports Q3 EPS $2.79, consensus $2.72 06/22/22 Notable companies reporting before tomorrow's open ACN Accenture $299.36 / +13.3 (+4.65%) 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 06/23/22 Fly Intel: Pre-market Movers 03/17/22 What You Missed On Wall Street On Thursday 09/22/22 Accenture - ACN ACN Accenture $299.36 / +13.3 (+4.65%) 06/10/22 Accenture call volume above normal and directionally bullish 04/20/22 Largest borrow rate increases among liquid names
Recommendations	Merck price target raised to $102 from $95 at Cowen » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 MRK Merck $93.22 / +1.14 (+1.24%) , SGEN Seagen $179.14 / +5.07 (+2.91%) Cowen analyst Boris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06:57 Today AstraZeneca, Merck announce LYNPARZA receives positive opinion from CHMP 06:18 Today AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer 06/24/22 European Commission approves KEYTRUDA as adjuvant treatment for melanoma 06/24/22 Merck: EC approves KEYTRUDA for treatment of stage IIB or IIC melanoma SGEN Seagen $179.14 / +5.07 (+2.91%) 06/17/22 Seattle Genetics trading resumes 06/17/22 Seagen jumps 10% to $161.79 after WSJ report of Merck interest 06/17/22 Seattle Genetics trading halted, volatility trading pause 06/06/22 Seagen, Genmab present data from tisotumab vedotin clinical development program MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer 04/12/22 Barclays Merck price target raised to $97 from $94 at Barclays 04/11/22 H.C. Wainwright Rubius Therapeutics price target lowered to $15 from $40 at H.C. Wainwright SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 Mizuho Merck deal would add 'novel and validated technology,' says Mizuho 06/23/22 BMO Capital Seagen initiated with a Market Perform at BMO Capital 06/21/22 Morgan Stanley Seagen named 'Catalyst Driven Idea' at Morgan Stanley 06/21/22 Oppenheimer Seagen price target raised to $208 from $160 at Oppenheimer MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 04/28/22 Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24 04/28/22 Merck reports Q1 adjusted EPS $2.14, consensus $1.83 04/27/22 Notable companies reporting before tomorrow's open 04/27/22 Notable companies reporting before tomorrow's open SGEN Seagen $179.14 / +5.07 (+2.91%) 04/28/22 Seagen sees FY22 total revenue $1.665B-$1.745B, consensus $1.78B 04/28/22 Seagen reports Q1 EPS (74c), consensus ($1.00) 02/10/22 Seagen sees FY22 total revenue $1.67B-$1.75B, consensus $2.16B 02/09/22 Seagen reports Q4 EPS (95c), consensus (83c) MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports 05/31/22 Pfizer's Paxlovid becomes leading pandemic pill, WSJ reports SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 Merck moving forward with potential Seagen deal, WSJ reports 06/17/22 Merck, other suitors interested in acquiring Seagen, WSJ reports 06/17/22 Merck considering acquisition of Seagen, WSJ reports MRK SGEN MRK Merck $93.22 / +1.14 (+1.24%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday SGEN Seagen $179.14 / +5.07 (+2.91%) 06/24/22 What You Missed On Wall Street On Friday 06/24/22 What You Missed On Wall Street This Morning 06/24/22 Fly Intel: Pre-market Movers 06/17/22 What You Missed On Wall Street On Friday 07/28/22 Merck - MRK 07/01/22 Extended PDUFA Date for Vaxneuvance 01/29/23 PDUFA Date for new sBLA for KEYTRUDA 10/04/22 Merck MRK MRK Merck $93.22 / +1.14 (+1.24%) 06/01/22 Merck put volume heavy and directionally bearish 05/31/22 Merck put volume heavy and directionally bearish 05/18/22 Merck put volume heavy and directionally bearish 04/04/22 Merck call buyer realizes 64% same-day gains

Hot Stocks	Clover's COVID vaccine candidate shows 'strong' neutralization against variant » 07:39 06/27/22 06/27 07:39 06/27/22 07:39 DVAX Dynavax $12.34 / +0.07 (+0.57%) China's Clover… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/17/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 05/12/22 Dynavax to replace Bottomline Technologies in S&P 600 at open on 5/17 02/28/22 Dynavax sees FY22 CpG 1018 adjuvant net product revenues of $550M 12/28/21 Dynavax notes Biological E's CORBEVAX received DCGI emergency use approval DVAX Dynavax $12.34 / +0.07 (+0.57%) 01/05/22 Goldman Sachs Goldman reinstates Dynavax at Buy, sees value creation from COVID platform 12/29/21 H.C. Wainwright Dynavax price target raised to $28 from $23 at H.C. Wainwright 08/31/21 H.C. Wainwright Dynavax price target raised to $23 from $20 at H.C. Wainwright 08/05/21 Goldman Sachs Dynavax initiated with a Buy at Goldman Sachs DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/05/22 Dynavax still sees 2022 CpG 1018 adjuvant revenues at least $550M 05/05/22 Dynavax reports Q1 EPS 26c, consensus 24c 02/28/22 Dynavax reports Q4 EPS 55c, consensus 64c DVAX Dynavax $12.34 / +0.07 (+0.57%) 05/12/22 Fly Intel: After-Hours Movers
Hot Stocks	TG Therapeutics presents exploratory analyses from ublituximab in MS trial » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) TG Therapeutics … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/03/22 TG Therapeutics announces data presentations from ULTIMATE I, II Phase 3 trials 05/31/22 TG Therapeutics announces FDA extension of BLA PDUFA date for ublituximab 04/15/22 TG Therapeutics withdraws leukemia application, pulls Ukoniq from sale 04/06/22 TG Therapeutics announces presentation of ULTIMATE I & II Phase 3 trial data TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/13/22 B. Riley TG Therapeutics price target lowered to $17 from $23 at B. Riley 05/20/22 BofA BofA starts TG Therapeutics at Underperform, sees difficult commercial setup 05/20/22 BofA TG Therapeutics initiated with an Underperform at BofA 04/19/22 B. Riley TG Therapeutics application withdrawal 'clearing event,' says B. Riley TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 03/01/22 TG Therapeutics reports Q4 EPS (70c), consensus (63c) TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 04/18/22 What You Missed On Wall Street On Monday 04/18/22 What You Missed On Wall Street This Morning 01/27/22 Wall Street in Fives - Must Read Lists for Thursday 01/27/22 Wall Street in Fives - Must Read Lists at Midday TGTX TG Therapeutics $4.39 / -0.235 (-5.08%) 06/09/22 Unusually active option classes on open June 9th 04/29/22 TG Therapeutics call volume above normal and directionally bullish
Recommendations	Televisa price target lowered to $13 from $15.50 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 TV Televisa $8.71 / +0.34 (+4.06%) JPMorgan analyst Marcelo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly TV Televisa $8.71 / +0.34 (+4.06%) 06/01/22 Goldman Sachs Televisa reinstated with a Neutral at Goldman Sachs 03/23/22 Barclays Televisa upgraded to Equal Weight from Underweight at Barclays 03/18/22 JPMorgan America Movil downgraded to Neutral from Overweight at JPMorgan 03/18/22 JPMorgan Televisa resumed with Overweight from Neutral at JPMorgan TV Televisa $8.71 / +0.34 (+4.06%) 03/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	Copa Holdings price target lowered to $76 from $90 at JPMorgan » 07:38 06/27/22 06/27 07:38 06/27/22 07:38 CPA Copa Holdings $63.84 / +2.61 (+4.26%) JPMorgan analyst Fernando… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CPA Copa Holdings $63.84 / +2.61 (+4.26%) 06/10/22 Copa Holdings reports preliminary May traffic down 4.2%, capacity down 3.7% 05/10/22 Copa Holdings reports preliminary April traffic statistics 04/13/22 Copa Holdings reports preliminary March traffic statistics 03/10/22 Copa Holdings reports preliminary February traffic down 13% vs. 2019 CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/13/22 Barclays Barclays double upgrades Copa Holdings on improving operations 05/13/22 Barclays Copa Holdings upgraded to Overweight from Underweight at Barclays 04/13/22 Raymond James Copa Holdings price target lowered to $110 from $115 at Raymond James 02/23/22 Barclays Copa Holdings price target raised to $96 from $82 at Barclays CPA Copa Holdings $63.84 / +2.61 (+4.26%) 05/11/22 Copa Holdings reports Q1 EPS 47c, consensus 29c 02/09/22 Copa Holdings reports Q4 EPS ex-items $1.98, consensus 89c
Hot Stocks	DocGo to be added to Russell 2000 Index » 07:37 06/27/22 06/27 07:37 06/27/22 07:37 DCGO DocGo $7.11 / -0.39 (-5.20%) DocGo announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DCGO DocGo $7.11 / -0.39 (-5.20%) 05/24/22 DocGo announces $40M share repurchase plan 05/17/22 DocGo expands mobile health services with Carnival 04/26/22 DocGo, Jefferson Health partner for patient transport 03/30/22 DocGo unit Ambulnz Community Partners awarded three 'sizeable' contracts DCGO DocGo $7.11 / -0.39 (-5.20%) 05/11/22 Canaccord DocGo price target lowered to $10 from $13 at Canaccord 04/19/22 Deutsche Bank DocGo initiated with a Buy at Deutsche Bank 01/19/22 Stifel DocGo initiated with a Buy at Stifel 01/04/22 Northland DocGo named a top pick for 2022 at Northland DCGO DocGo $7.11 / -0.39 (-5.20%) 05/09/22 DocGo backs FY22 revenue view $400M-$420M, consensus $410.59M 05/09/22 DocGo reports Q1 EPS 9c, consensus 4c 03/14/22 DocGo sees FY22 revenue $400M-$420M, consensus $385.2M 03/14/22 DocGo reports Q4 net income $20.3M vs. ($4.4M) last year DCGO DocGo $7.11 / -0.39 (-5.20%) 01/11/22 Nine new option listings on January 11th

Events

Earnings calls, analyst events, roadshows and more

THO
Today at 09:00

Thor Industries Firm Sponsored Meetings

Airstream Headquarters, Jackson Center, OH
Today at 09:00

Technology/EV Supply Chain Industry Meetings
QRTEA
Today at 09:30

Qurate Retail Firm Sponsored Meetings

Virtual Meeting
NPSNY
Today at 10:00

Naspers - NPSNY Conference Calls
Today at 10:00

Consumer Industry Meetings
UTHR
Today at 10:30

United Therapeutics Corporation Firm Sponsored Meetings
DELL
Today at 10:30

Dell Technologies Inc. CL C Firm Sponsored Meetings
ORGN
Today at 11:00

Origin Materials Inc. Firm Sponsored Meetings
NTAP
Today at 11:30

NetApp - NTAP Conference Calls
Today at 13:00

Healthcare Facilities & Managed Care Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	IE X IE Ivanhoe Electric IPO Managers: BMO Capital & Jefferies, JPMorgan, Raymond James, RBC Capital, Scotiabank $11.75-12.50 14.388M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TUYA X TUYA Tuya Secondary Managers: CICC, BofA, Morgan Stanley & CMBI $2.30 7.3M Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Julius Baer upgraded to Buy from Neutral at UBS

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access